Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001775:Blood Circulation / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D001949:Bretylium Compounds / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects*; D002339:Carotid Arteries; D004285:Dogs; D005263:Femoral Artery; D006339:Heart Rate / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D010425:Pentolinium Tartrate / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011413:Propantheline / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D007093:Imidazoles; D010643:Phenoxybenzamine; D011413:Propantheline; D001285:Atropine; D012110:Reserpine; D010425:Pentolinium Tartrate; D011433:Propranolol